Personalized drug attack on salivary gland tumors shows promise
NCT ID NCT05924256
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving targeted drugs based on the genetic makeup of a person's advanced salivary gland cancer can shrink tumors or stop them from growing. About 88 adults with cancer that has spread or come back are enrolled. Researchers are checking how well these treatments work and how safe they are.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SALIVARY GLAND CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dongmei Ji
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.